Stock CHGCY CHUGAI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Chugai Pharmaceutical Co., Ltd. OTC Markets

Equities

CHGCY

US1712691039

Market Closed - OTC Markets
Other stock markets
 20:59:59 28/06/2024 BST 		5-day change 1st Jan Change
17.77 USD -1.77% Intraday chart for Chugai Pharmaceutical Co., Ltd. +10.65% -5.73%
06-24 Japan's Nikkei ends choppy session on stronger note RE
06-24 Japan's Nikkei squeezes out gains in choppy session RE

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Ex-dividend day for interim dividend
FA
Japan's Nikkei ends choppy session on stronger note
RE
Japan's Nikkei squeezes out gains in choppy session
RE
Japan's Nikkei rises on US stocks, heavyweight chip shares
RE
Tech stocks lift Japan's Nikkei on boost from Nvidia's robust outlook
RE
Japan's Nikkei drifts sideways as more earnings, US CPI awaited
RE
Chugai Pharmaceutical Allots 594 Million Yen Worth of Shares as Restricted Stock Compensation
MT
Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5%
MT
Chugai Pharmaceutical's Profit Slightly Up in Q1
MT
Chugai Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending December 31, 2024; Provides Dividend Guidance for the Year Ending December 31, 2024
CI
Japan's Nikkei slips on caution ahead of US inflation data
RE
Chugai Pharmaceutical to Allocate 594 Million Yen of Treasury Shares as Restricted Stock Compensation
MT
Roche's Chugai Wins Japanese Approval for Piasky Injection
MT
Global markets live: Sanofi, ABB, Qualcomm, Roche, Shell...
Our Logo
Chugai Pharmaceutical’s Profit Down 13% in 2023
MT
Chugai Pharmaceutical Co., Ltd. Provides Consolidated Non-Audited Earnings Guidance for the Financial Year 2024
CI
Final dividend
FA
From scandal to delisting: Toshiba's long-running crisis
RE
Chugai Pharmaceutical’s Attributable Profit down 13.9% in Fiscal due to One-Off Lump-Sum Settlement;Shares Shed over 2.6%
MT
Chugai Parent Roche Settles US Lawsuit Against Biogen Over Alleged Biosimilar Infringement
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4519 Stock
  4. CHGCY Stock
  5. News Chugai Pharmaceutical Co., Ltd.
  6. Highlights